An Evaluation of Vijaya Extract (Cannabryl Full Spectrum) For Pain Management in Cancer Patients as an Adjuvant Therapy in Palliative Care: A Pilot Study
Main Article Content
Keywords
Vijaya Extract; Cannabryl Full Spectrum; Cancer pain; Palliative care; Adjuvant therapy; Ayurveda.
Abstract
Background: Pain is one of the most common and distressing symptoms in cancer patients, particularly during advanced stages where palliative care becomes the primary focus. Despite the availability of conventional analgesics, effective pain control remains challenging due to their well known adverse effects, tolerance, and limited long-term compliance. Ayurveda describes several drugs possessing Vedanahara and Shoolaprashamana ( analgesic) properties that may offer complementary benefits in pain management.
Objective: The objective of the study is to evaluate the efficacy of Vijaya Extract (Cannabryl Full Spectrum) for pain management in cancer patients as an adjuvant therapy in palliative care.
Materials and Methods: This pilot study included 20 cancer patients suffering from pain, attended the Sangyaharan Vedanahara OPD, Sir Sunder Lal Hospital, Institute of Medical Sciences, Banaras Hindu University. Patients of either sex fulfilling the inclusion criteria were enrolled after obtaining written informed consent. Vijaya Extract (Cannabryl Full Spectrum) was administered orally (Sub lingual) mixed with melted cow ghee half TSF twice daily along with standard palliative care. Pain assessment scales, biochemical markers such as dopamine, serotonin, homocysteine, epinephrine and noradrenaline and hemodynamic parameters – Blood Pressure and Pulse rate were recorded at baseline (Day 0) and at the end of a 30-days follow-up period (Day 30).
Results: The study demonstrated improvement in pain scores and favorable trends in biochemical markers without significant adverse effects.
Conclusion: From the result of current study, we can conclude that Vijaya Extract (Cannabryl Full Spectrum) is an effective adjuvant therapy for pain management in palliative cancer care as an adjuvant and may provide a basis for future large-scale clinical trials.
References
Portenoy RK. Cancer pain: pathophysiology and syndromes. Lancet. 1992 Apr 25;339(8800):1026-31. doi: 10.1016/0140-6736(92)90545-e. PMID: 1349060.
Carlson CL. Effectiveness of the World Health Organization cancer pain relief guidelines: an integrative review. J Pain Res. 2016 Jul 22; 9:515-34. doi: 10.2147/JPR.S97759. PMID: 27524918; PMCID: PMC4965221.
Portenoy RK, Lesage P. Management of cancer pain. Lancet. 1999 May 15;353(9165):1695-700. doi: 10.1016/S0140-6736(99)01310-0. PMID: 10335806.
Bennett MI, Rayment C, Hjermstad M, Aass N, Caraceni A, Kaasa S. Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain. 2012 Feb;153(2):359-365. doi: 10.1016/j.pain.2011.10.028. Epub 2011 Nov 23. PMID: 22115921.
Cluxton C. The Challenge of Cancer Pain Assessment. Ulster Med J. 2019 Jan;88(1):43-46. Epub 2019 Jan 22. PMID: 30675079; PMCID: PMC6342038.
Smith HS. Opioid metabolism. Mayo Clin Proc. 2009 Jul;84(7):613-24. doi: 10.1016/S0025-6196(11)60750-7. PMID: 19567715; PMCID: PMC2704133.
Judith A. Paice et al. Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline. J Clin Oncol 41, 914-930(2023). DOI:10.1200/JCO.22.02198
Deng G, Cassileth BR. Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance. CA Cancer J Clin. 2005 Mar-Apr;55(2):109-16. doi: 10.3322/canjclin.55.2.109. PMID: 15761079.
Sharma PV. Dravyaguna Vijnana. Vol 2. Varanasi: Chaukhambha Bharati Academy; 2013:1–40.
Dash B, Sharma RK. Caraka Samhita. Varanasi: Chaukhambha Sanskrit Series; 2014:1–55.
Tripathi B. Ashtanga Hridaya. Varanasi: Chaukhambha Sanskrit Pratishthan; 2012:1–50.
Russo EB. Cannabinoids in the management of difficult to treat pain. Ther Clin Risk Manag. 2008 Feb;4(1):245-59. doi: 10.2147/tcrm. s1928. PMID: 18728714; PMCID: PMC2503660.
Carlson CL. Effectiveness of the World Health Organization cancer pain relief guidelines: an integrative review. J Pain Res. 2016 Jul 22; 9:515-34. doi: 10.2147/JPR.S97759. PMID: 27524918; PMCID: PMC4965221.
Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA. 2015;313(24):2456–2473. doi:10.1001/jama.2015.6358
Sproston NR, Ashworth JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Immunol. 2018 Apr 13; 9:754. doi: 10.3389/fimmu.2018.00754. PMID: 29706967; PMCID: PMC5908901.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Kuldeep Kumar Pandey
Department of Sangyaharan, Faculty of Ayurveda, Institute of Medical Science, BHU, Varanasi-221005
Pradip Kumar Mishra
Department of Sangyaharan, Faculty of Ayurveda, Institute of Medical Science, BHU, Varanasi-221005
Kavita
Department of Medicinal Chemistry, Faculty of Ayurveda, Institute of Medical Science, BHU, Varanasi-221005
Neha Garg
Department of Medicinal Chemistry, Faculty of Ayurveda, Institute of Medical Science, BHU, Varanasi-221005
Deepti Vats
Director, Indogenix Biosciences LLP, Bhopal, Madhya Pradesh, India-462026
